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In Togo as elsewhere, among the animal trypanosomosis c ntrol strategies, the chemotherapy constitutes 
the most used method. In order to assess the efficiency of two trypanocidal drugs (isometamidium chloride and 
diminazene) on cattle, a longitudinal study was conducted from September to November 2011 in the reseach 
station of Avetonou located in the Prefecture of Agou in Togo. A parasitological survey was carried out on two 
groups of 90 cattle each (for a total of 180 cattle) using the buffy coat technique at regular intervals of two 
weeks over a total period of 56 days. The animals of the first group were treated with isometamidium chloride 
(0.5 mg/kg) and the second group (untreated animals) wa  used as a control group. The comparison of the 
incidence of trypanosomosis between the two groups wa performed using three statistical tests: the Chi-
squared test, the test of risk Reduction, and the “Eisler ratio test”. These analyses revealed an ineffici ncy of the 
preventive treatment with isometamidium chloride at the dose of 0.5 mg/kg bodyweight contrarily to the 
curative treatment that was effective. For diminazee, used at a dose of 3.5 mg/kg bodyweight, strains of 
Trypanosoma vivax and Trypanosoma congolense were not eliminated in 14.29% of cases. 
© 2014 International Formulae Group. All rights reserved. 
 




Bovine trypanosomosis remains one of 
major constraint to agricultural development 
in sub-Saharan Africa. The diseases are 
caused by blood parasites called Trypanosoma 
sp. transmitted by tsetse flies, the main 
vectors. African animal trypanosomosis 
(AAT) are present in the best land of Africa. 
In cattle, control methods involve either tsetse 
control or treatment of animals with 
trypanocidal drugs (diminazene and 
isometamidium chloride) in a therapeutic or 
prophylactic approach. The two trypanocidal 
drugs are accessible to breeders and 
veterinarians for their relative cheap cost in 
the market and low toxicity. Unfortunately, 
their widespread use, especially prolonged 
and incorrect, leads to the emergence of 
strains of multi drug-resistant trypanosomes 
whose consequence is that many cases of 
trypanosome infections cannot be prevented 
or cured in a sustainable way (Eisler et al., 
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2000; Chaka and Abebe, 2003). In West 
Africa, trypanocidal drug resistance has been 
reported in several countries, including 
Burkina Faso (Pinder and Authié, 1984; 
Clausen et al., 1992; McDermott et al., 2000; 
Talaki et al., 2007), Ivory Coast, Nigeria 
(Peregrine, 1994, cited by Geerts and Holmes, 
1998), Guinea, Mali (Talaki, 2011), Ghana 
(Allegye-Cudjoe et al., 2009) and Benin 
(Vitouley et al., 2013). In Togo, cases of 
resistance to trypanocides were reported in the 
north of the country, in the savannah region 
and more specifically in the prefecture of Oti 
(Boma, 2012 cited by Talaki et al., 2013). In 
all cases, this phenomenon is probably 
underestimated because the situation is 
unclear in many places that either 
investigations have not been conducted, or the 
results of the studies are not published. It is in 
this context that this study was conducted at 
the Research Station of Avétonou/ITRA-
Togo, following numerous deaths recorded in 
spite of trypanocidal treatments performed 
against animal trypanosomosis. 
 
MATERIALS AND METHODS  
Study area  
The study area (Research Station of 
Avétonou) is located in Agou prefecture 
(Plateau Region) (longitude: from 0° 40' to 0° 
55' East, latitude: from 6° 40' to 6° 55' North) 
and covers about 650 ha. The area is covered 
by savannah mixed with gallery forests. 
Herbaceous stratum, consisting of 
Andropogon sp. and Panicum sp., dominates 
the vegetation. On hydrography plan, the Zio 
River located approximately 0.8 km northeast 
of the station, is with its tributaries, the most 
important river system. The climate is sudano-
guinean tropical type and can be divided into 
two rainy seasons (from March to June and 
September to October) and two dry seasons 
(from July to August and from November to 
February). The area has 1.000 -2.000 mm of 
rainfall per year with large inter-annual 
variations. The landscape of Agou prefecture 
is essentially marked by Agou Mountain with 
a peak at 986 m. The main economic activities 
are agriculture and breeding. The study area 
has a favourable biotope for tsetse-infestation. 
Longitudinal survey  
Cattle of Avetonou station were 
monitored from 22nd September to 17th 
November 2011 to assess the resistance of 
trypanosomes to isometamidium chloride.  
Two groups of cattle were formed: a 
treated group (with isometamidium) and a 
control group (untreated animals). In each 
herd, the choice of individuals belonging to 
treated group or control group has been done 
randomly according to the order of animals 
through the contention lane. All animals in the 
test group were treated with isometamidium 
chloride at a dose of 0.5 mg/kg body weight 
while only cattle detected positive in the 
control group were treated with diminazene 
dose 3.5 mg/kg body weight (curative dose). 
The day of treatment with isometamidium was 
considered as day 0 (starting point, D0). 
Animals were monitored every two weeks 
using parasitological examinations by buffy 
coat technique (Murray et al., 1977). Thus, 
animals were examined five times on the dates 
D0, D14, D28, D42 and D56 in both groups 
(Table 1) and the study period covered eight 
weeks. 
 
Data statistical analysis 
Data were entered in Microsoft Excel 
database. The resistance to isometamidium 
was evaluated by comparing the incidence of 
trypanosome infections in both groups 
(control and test group) using different 
statistical tests: Chi-squared test (Chi2), 
Relative Risk Reduction (RRR) and "Eisler 
ratio test" (Eisler et al., 2000). The data were 
analysed according to the method of Talaki et 
al. (2007): (i) a numbering of new infections 
from D14; (ii) a single entry of any animal 
tested positive during the corresponding 
monitoring period; (iii) any animal tested 
negative in previous controls and absent to the 
last control of the corresponding monitoring is 
not taken into account. It is then considered as 
a lost pet and therefore is subtracted from the 
effective monitoring; (iv) a consideration of 
any animal present on the last corresponding 
control monitoring even though it was 
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Table 1: Longitudinal survey protocol. 
 
Groups                            Do D14, D28, D42 and D56 
 
Test group  
 
- Parasitological examination by Buffy 
Coat Technique (Murray et al., 1977)  
-  Isometamidium to all animals  
- Parasitological examination by Buffy 
Coat Technique (Murray et al., 1977) 




- Parasitological examination by Buffy 
Coat Technique (Murray et al., 1977) 
 - Diminazene to positive animals  
- Parasitological examination by Buffy 
Coat Technique (Murray et al., 1977) 




Evaluation of treatment with 
isometamidium  
Preventive effect 
New infections were recorded in both 
groups between D0 and D56. In the test group 
(treated with isometamidium), the incidence 
was 32.58% (ie 29 new infections registered 
in 89 animals). In the control group, the 
incidence of trypanosome infections was 
45.88% (ie 39 new infections on a really 
effective monitoring of 85 animals). The 
results of comparison between the two groups 
(over 56 days) using Chi2 test are given in 
Table 2. The differences were not significant 
(Chi2 value = 3.294) between the two groups 
(treated and untreated) reflecting the 
ineffectiveness of preventive treatment with 
isometamidium dose of 0.5 mg/kg body 
weight. 
The results of "Eisler ratio test" are 
recorded in Table 3. The ratio of the risk of 
infection by dividing the risk in the control 
group and the one in the test group gave a 
value of 1.34. This showed the inefficiency of 
isometamidium at a dose of 0.5 mg/kg body 
weight, thus confirming the results of the 
previous analysis. Indeed, Eisler et al. (2000) 
have suggested that resistance to 
isometamidium can be suspected when this 
ratio is less than 2; which is equivalent to a 
reduction of the risk of infection in the test 
group of less than 50% compared to the 
control group. 
Finally, the results of the Relative Risk 
Reduction (RRR) and its confidence interval 
at 95% are shown in Table 4. From the lower 
bound of the confidence interval (0.487), we 
determined the maximum rate of protection 
conferred by isometamidium (51.3%) and 
deducted the corresponding minimum failure 
rate (48.7%). The problem in this approach of 
analysis is the absence of a consensus 
threshold of failure rate from which we can 
conclude the presence of chemoresistance. 
Adopting 15% (Talaki et al., 2007) and even 
25% (WHO, 2004) as the threshold value of 
failure rate from which we can conclude a 
resistance to trypanocidal drugs, it leads to 
inefficiency of preventive treatment with 
isometamidium at a dose of 0.5 mg/kg body 
weight. 
Curative effect  
The curative effect of isometamidium 
at a dose of 0.5 mg/kg body weight was 
evaluated by the rate of relapse on the 
fourteenth day post-treatment (D14) in the test 
group. From a total of 20 positive animals 
treated on D0, no cases of relapse were 
detected at D14. In other words, the cure with 
isometamidium at a dose of 0.5 mg/kg 
bodyweight was effective. 
 
Evaluation of treatment efficiency to 
diminazene 
Only the animals in the control group 
were taken into account for this evaluation. 
Thus, positive animals, treated with 
diminazene (3.5 mg/kg body weight) on D0 
and having undergone a parasitological 
control the fourteenth day post-treatment were 
considered. Of the 21 animals treated at D0, 
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only three have been tested positive on D14, a 
rate of 14.29% post-treatment relapse. Taking 
15% (Talaki et al., 2007) as threshold value, 
we cannot conclude with certainty ineffective 
therapy to diminazene since this failure rate of 
treatment (14.29%) is very close to the 
threshold value of 15%. With a threshold 
value of 25% (WHO, 2004) used for malaria 
control, we can conclude that the curative 
effect of diminazene was effective. 
  
  
Table 2: Results of the Chi2 test. 
 
 Test group (ISMM) Control group           Value Chi2             
Conclusion  
(5% level) 







Lost 1 5 
Number monitored 89 85 
Positive (new infections) 29 39 




Table 3: Results of "Eisler’s Ratio Test ". 
 
 Test group (ISMM) Control group     
"Eisler’s 
Ratio" value    
Conclusion 




Lost 1 5 
Number monitored               89 85 
Positive (new infections)  29 39 




Table 4: Relative Risk Reduction (RRR). 
  
 Test batch 
Control 
Batch 





Monitored        
89 85      






Positive (%)             32.58 45.88      










Preventive effect of isometamidium 
Drug resistance is defined as the 
heritable loss of susceptibility of a population 
of microorganisms previously sensitive to a 
molecule. The results of the three tests used 
(Chi2 test, "Eisler’s Ratio" and the calculation 
of the Relative Risk Reduction (RRR) and its 
confidence interval) showed that treated 
animals are also exposed to a high risk of 
infection. Hence, it appears that 
isometamidium chloride at a dose of 0.5 
mg/kg body weight did not provide cross-
protection of animals against trypanosomes 
for a period of three months. This 
ineffectiveness of preventive therapy to 
isometamidium had already been reported by 
some authors in other countries such as 
Burkina Faso, Guinea and Mali where 
isometamidium treatments at a dose of 1 
mg/kg body weight was not sufficient to 
protect animals over a period of 56 days 
(Talaki, 2011). Indeed, prophylactic doses 
recommended for isometamidium chloride are 
ranging from 0.5-1 mg/kg body weight and 
the molecule has also shown remarkable 
activity in zebu cattle in East Africa (Trail et 
al., 1985; Moloo et al., 1987). Although 
significant changes in the duration of 
protection going from 2 to 22 weeks have 
been noted by many authors (Kirby, 1964; 
Pinder and Authié, 1984; Whitelaw et al., 
1986; Peregrine et al., 1991), they seem not to 
depend upon the size of the risk of the disease, 
nor on the presence of infection nor on the 
time of treatment (Peregrine et al., 1988). In 
this study, could a treatment with 1 mg/kg 
body weight instead of 0.5 mg/kg provide 
protection for animals? The question remains 
open and deserves further investigation. 
Moreover, if the parasitological monitoring of 
animals by the method of Eisler et al. (2000) 
is the basic approach for evaluating the 
resistance of isometamidium on field, this 
method requires follow-up sessions with 
parasitological observations at regular 
intervals of 14 days, increasing the work time 
both for research teams and for farmers who 
have to spend a lot of time for control 
sessions. More the monitoring of animals is 
too long, less is the participation of animal’s 
breeders and the number of dropouts during 
the experiments increases. When the dropouts 
become very important, data analysis will be 
complicated and sometimes it can lead to 
difficulties or impossibility to interpret results. 
 
Curative effect of isometamidium and 
diminazene 
The results of this study revealed an 
effective cure with isometamidium at a dose 
of 0.5 mg/kg bodyweight, unlike preventive at 
the same dose of the trypanocide treatment. 
Normally, diminazene is efficient at a dose of 
3.5 mg/kg body weight on Trypanosoma vivax 
and T. congolense strains but, in the present 
study, we observed 14.29% of relapse. Indeed, 
for curative use, isometamidium chloride is 
used at the doses between 0.25 and 0.5 mg/kg 
body weight and was effective in the 
treatment of animal trypanosomosis 
(Petrovskii, 1974). For diminazene, the dose 
of 3.5 mg/kg body weight is sufficient to 
eliminate sensitive strains of T. vivax and T. 
congolense while T. brucei requires a higher 
dose up to 7 mg/kg body weight (Fussgänger 
and Bauer, 1958).  
In this study, regarding the curative 
effect of the two trypanocidal drugs 
(isometamidium and diminazene), infections 
observed on D14 could be considered as 
relapses and those observed later as re-
infections. The failure rates reported here 
were certainly underestimated because of the 
impossibility of taking into account the late 
relapses. Also, the technique of parasitological 
diagnosis and post-processing performed on 
the fourteenth day control (whether for 
isometamidium or diminazene), have certainly 
underestimated the failure rate considering the 
fact that the parasite diagnosis with BCT is 
not very sensitive. Further studies using PCR 
(Polymerase Chain Reaction) are needed 
because this technique is more sensitive than 
BCT and could increase parasitological 
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prevalence rate 2.5 times higher than the BCT 
method (Desquesnes et al., 1999).  
 
Conclusion 
Animal trypanosomosis is still a constraint to 
livestock development in the Avetonou station 
of the Institute of Agricultural Research of 
Togo. To control the disease in animals, two 
trypanocidal drugs are used: isometamidium 
chloride and diminazene. Results of this study 
showed ineffectiveness of prophylactic 
treatment with isometamidium chloride at a 
dose of 0.5 mg/kg b.w. Further study is 
needed to assess the prophylactic effect of 
isometamidium chloride with 1 mg/kg b.w. 
For curative effect, isometamidium showed an 
efficiency at a dose of 0.5 mg/kg b.w. For 
diminazene, the treatment failure rate 
recorded was in tolerable limits. 
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